News Earnings DCM Shriram Fine Chemicals Limited Reports Q3 FY26 Financial Results with Net Loss of Rs. 162 LakhsDCM Shriram Fine Chemicals Limited Reports Q3 FY26 Financial Results with Net Loss of Rs. 162 Lakhs
DCM Shriram Fine Chemicals Limited reported Q3 FY26 results showing a net loss of Rs. 162 lakhs versus a profit of Rs. 220 lakhs in Q3 FY24, despite revenue growth of 3.86% to Rs. 9,695 lakhs. Nine-month performance showed a net loss of Rs. 21 lakhs compared to Rs. 1,419 lakhs profit in the previous year, with revenue declining 7.53% to Rs. 29,247 lakhs. The company completed a significant corporate restructuring during the period and listed its shares in February 2026.
*this image is generated using AI for illustrative purposes only.
DCM Shriram Fine Chemicals Limited announced its unaudited financial results for the quarter and nine months ended December 31, 2025, marking a challenging period for the specialty chemicals manufacturer. The company reported a net loss during the quarter, reflecting operational pressures despite maintaining revenue levels.
Financial Performance Overview
The company's financial performance showed mixed results across different metrics. Revenue from operations demonstrated resilience, while profitability faced significant headwinds during the reporting period.
| Metric | Q3 FY26 | Q3 FY25 | Q3 FY24 | Change (Q3 FY26 vs Q3 FY24) |
|---|---|---|---|---|
| Revenue from Operations | Rs. 9,695 lakhs | Rs. 9,690 lakhs | Rs. 9,335 lakhs | +3.86% |
| Net Sales | Rs. 9,601 lakhs | Rs. 9,622 lakhs | Rs. 9,269 lakhs | +3.58% |
| Total Income | Rs. 9,759 lakhs | Rs. 9,732 lakhs | Rs. 9,407 lakhs | +3.74% |
| Net Profit/(Loss) | Rs. (162) lakhs | Rs. (346) lakhs | Rs. 220 lakhs | Loss vs Profit |
Nine-Month Performance Analysis
The nine-month period ended December 31, 2025, revealed more pronounced challenges compared to the quarterly performance. The company's operational metrics showed significant year-over-year variations.
| Parameter | Nine Months FY26 | Nine Months FY25 | Change |
|---|---|---|---|
| Revenue from Operations | Rs. 29,247 lakhs | Rs. 31,629 lakhs | -7.53% |
| Net Sales | Rs. 29,016 lakhs | Rs. 31,446 lakhs | -7.73% |
| Total Expenses | Rs. 29,351 lakhs | Rs. 29,922 lakhs | -1.91% |
| Net Profit/(Loss) | Rs. (21) lakhs | Rs. 1,419 lakhs | Loss vs Profit |
Cost Structure and Operational Metrics
The company's cost structure revealed several key trends during the quarter. Cost of materials consumed decreased to Rs. 5,475 lakhs in Q3 FY26 from Rs. 6,162 lakhs in Q3 FY24. Employee benefits expense also declined to Rs. 1,294 lakhs from Rs. 1,378 lakhs in the corresponding previous quarter. However, other expenses increased significantly to Rs. 2,709 lakhs from Rs. 2,234 lakhs, contributing to the overall loss.
Corporate Developments
During the reporting period, the company completed a significant corporate restructuring through a Composite Scheme of Arrangement. The National Company Law Tribunal sanctioned the scheme on November 21, 2025, which became effective on December 17, 2025. Under this arrangement, DCM Shriram Industries Limited transferred net assets aggregating Rs. 15,336 lakhs and surplus of Rs. 28,663 lakhs to the company.
The company's equity shares were listed on BSE Limited and National Stock Exchange of India Limited with effect from February 17, 2026. The paid-up equity share capital stands at Rs. 1,740 lakhs with a face value of Rs. 2 per equity share.
Earnings Per Share and Other Metrics
Basic and diluted earnings per share for Q3 FY26 stood at Rs. (0.19) compared to Rs. 0.25 in Q3 FY24. For the nine-month period, earnings per share was Rs. (0.02) against Rs. 1.63 in the corresponding previous period. The company operates primarily in manufacturing of organics and fine chemicals in India as a single business segment.
The financial results were reviewed by the Audit Committee and approved by the Board of Directors at their meeting held on March 2, 2026, with statutory auditor review conducted by Kirtane & Pandit LLP.
19
